Correlation Between Lyell Immunopharma and Immunovant

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Immunovant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Immunovant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and Immunovant, you can compare the effects of market volatilities on Lyell Immunopharma and Immunovant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Immunovant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Immunovant.

Diversification Opportunities for Lyell Immunopharma and Immunovant

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Lyell and Immunovant is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Immunovant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunovant and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Immunovant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunovant has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Immunovant go up and down completely randomly.

Pair Corralation between Lyell Immunopharma and Immunovant

Given the investment horizon of 90 days Lyell Immunopharma is expected to under-perform the Immunovant. In addition to that, Lyell Immunopharma is 1.07 times more volatile than Immunovant. It trades about -0.01 of its total potential returns per unit of risk. Immunovant is currently generating about 0.03 per unit of volatility. If you would invest  2,130  in Immunovant on September 1, 2024 and sell it today you would earn a total of  690.00  from holding Immunovant or generate 32.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lyell Immunopharma  vs.  Immunovant

 Performance 
       Timeline  
Lyell Immunopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lyell Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Immunovant 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunovant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Immunovant is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Lyell Immunopharma and Immunovant Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lyell Immunopharma and Immunovant

The main advantage of trading using opposite Lyell Immunopharma and Immunovant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Immunovant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunovant will offset losses from the drop in Immunovant's long position.
The idea behind Lyell Immunopharma and Immunovant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated